HEADER IMMUNE SYSTEM 26-SEP-02 1MVU TITLE SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH TITLE 2 SYNTHETIC EPITOPE PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG KAPPA-CHAIN VJ-REGION (LIGHT CHAIN); COMPND 3 CHAIN: A; COMPND 4 SYNONYM: C219 ANTIBODY LIGHT CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC COMPND 7 (GGGGS)3 LINKER; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: IG VDJ-REGION (HEAVY CHAIN); COMPND 10 CHAIN: B; COMPND 11 SYNONYM: C219 ANTIBODY HEAVY CHAIN; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC COMPND 14 (GGGGS)3 LINKER; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: P-GLYCOPROTEIN; COMPND 17 CHAIN: P; COMPND 18 FRAGMENT: ATP-BINDING DOMAIN (RESIDUES 1-13); COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELLULAR_LOCATION: PERIPLASM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TG1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSJF2; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 CELLULAR_LOCATION: PERIPLASM; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: TG1; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PSJF2; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 24 OF THE PEPTIDE IS NATURALLY FOUND IN CRICETULUS GRISEUS (CHINESE SOURCE 25 HAMSTER). KEYWDS SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, KEYWDS 2 IMMUNOGLOBULIN, SITE-DIRECTED MUTAGENESIS, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.C.M.CHAN,D.A.KUNTZ,D.R.ROSE REVDAT 3 18-SEP-13 1MVU 1 REMARK VERSN REVDAT 2 24-FEB-09 1MVU 1 VERSN REVDAT 1 07-OCT-03 1MVU 0 JRNL AUTH D.C.M.CHAN,T.HIRAMA,C.R.MACKENZIE,D.A.KUNTZ,D.R.ROSE JRNL TITL SINGLE CHAIN C219 V(101H)L MUTANT ANTIBODY COMPLEXED WITH A JRNL TITL 2 HELICAL PEPTIDE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.M.VAN DEN ELSEN,D.A.KUNTZ,F.J.HOEDEMAEKER,D.R.ROSE REMARK 1 TITL ANTIBODY C19 RECOGNIZES AN ALPHA-HELICAL EPITOPE ON REMARK 1 TITL 2 P-GLYCOPROTEIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 96 13679 1999 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.96.24.13679 REMARK 1 REFERENCE 2 REMARK 1 AUTH F.J.HOEDEMAEKER,T.SIGNORELLI,K.JOHNS,D.A.KUNTZ,D.R.ROSE REMARK 1 TITL A SINGLE CHAIN FV FRAGMENT OF P-GLYCOPROTEIN-SPECIFIC REMARK 1 TITL 2 MONOCLONAL ANTIBODY C219. DESIGN, EXPRESSION, AND CRYSTAL REMARK 1 TITL 3 STRUCTURE AT 2.4 A RESOLUTION REMARK 1 REF J.BIOL.CHEM. V. 272 29784 1997 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.272.47.29784 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 385673.560 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 22806 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1103 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3419 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1909 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.32000 REMARK 3 B22 (A**2) : 4.52000 REMARK 3 B33 (A**2) : 3.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.96000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.70 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 47.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MVU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-02. REMARK 100 THE RCSB ID CODE IS RCSB017228. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : QUARTZ CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23268 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, LITHIUM SULFATE, PH 9, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.48350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 113 REMARK 465 ARG A 114 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 57 -40.88 67.31 REMARK 500 ALA A 90 -177.72 176.14 REMARK 500 SER B 85 62.11 37.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AP2 RELATED DB: PDB REMARK 900 WILD TYPE C219 ANTIBODY REMARK 900 RELATED ID: 2AP2 RELATED DB: PDB REMARK 900 WILD TYPE C219 ANTIBODY WITH C219 BINDING PEPTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 AT THE TIME OF PROCESSING, NO DATABASE REFERENCE SEQUENCE REMARK 999 WAS AVAILABLE FOR C219 ANTIBODY HEAVY CHAIN. AUTHORS REMARK 999 INFORMED THAT RESIDUE 101 OF THIS CHAIN WAS MUTATED FROM REMARK 999 VAL TO LEU. DBREF 1MVU A 1 114 GB 196563 AAA38730 1 114 DBREF 1MVU P 1 13 GB 191155 AAA37004 1210 1222 DBREF 1MVU B 1 121 PDB 1MVU 1MVU 1 121 SEQADV 1MVU PRO A 112 GB 196563 LEU 112 CONFLICT SEQRES 1 A 114 ASP ILE VAL MET THR GLN SER PRO SER SER LEU THR VAL SEQRES 2 A 114 THR ALA GLY GLU LYS VAL THR MET SER CYS LYS SER SER SEQRES 3 A 114 GLN SER LEU LEU ASN SER GLY ASN GLN LYS ASN TYR LEU SEQRES 4 A 114 THR TRP TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU SEQRES 5 A 114 LEU ILE TYR TRP ALA SER THR ARG GLU SER GLY VAL PRO SEQRES 6 A 114 ASP ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR SEQRES 7 A 114 LEU THR ILE SER SER VAL GLN ALA GLU ASP LEU ALA VAL SEQRES 8 A 114 TYR TYR CYS GLN ASN ASP TYR SER TYR PRO LEU THR PHE SEQRES 9 A 114 GLY ALA GLY THR LYS LEU GLU PRO LYS ARG SEQRES 1 B 121 GLU VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL ARG SEQRES 2 B 121 PRO GLY ALA SER VAL LYS LEU SER CYS THR ALA SER GLY SEQRES 3 B 121 PHE ASN ILE LYS ASP ASP PHE MET HIS TRP VAL LYS GLN SEQRES 4 B 121 ARG PRO GLU GLN GLY LEU GLU TRP ILE GLY ARG ILE ASP SEQRES 5 B 121 PRO ALA ASN ASP ASN THR LYS TYR ALA PRO LYS PHE GLN SEQRES 6 B 121 ASP LYS ALA THR ILE ILE ALA ASP THR SER SER ASN THR SEQRES 7 B 121 ALA TYR LEU GLN LEU SER SER LEU THR SER GLU ASP THR SEQRES 8 B 121 ALA VAL TYR TYR CYS ALA ARG ARG GLU LEU TYR SER TYR SEQRES 9 B 121 TYR SER PRO LEU ASP VAL TRP GLY ALA GLY THR THR VAL SEQRES 10 B 121 THR VAL PRO SER SEQRES 1 P 13 VAL VAL GLN GLU ALA LEU ASP LYS ALA ARG GLU GLY ARG HET SO4 A 200 5 HETNAM SO4 SULFATE ION FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *190(H2 O) HELIX 1 1 GLN A 85 LEU A 89 5 5 HELIX 2 2 ASN B 28 LYS B 30 5 3 HELIX 3 3 PRO B 62 GLN B 65 5 4 HELIX 4 4 THR B 87 THR B 91 5 5 HELIX 5 5 VAL P 1 GLY P 12 1 12 SHEET 1 A 4 MET A 4 SER A 7 0 SHEET 2 A 4 VAL A 19 SER A 25 -1 O SER A 22 N SER A 7 SHEET 3 A 4 ASP A 76 ILE A 81 -1 O ILE A 81 N VAL A 19 SHEET 4 A 4 PHE A 68 SER A 73 -1 N THR A 69 O THR A 80 SHEET 1 B 5 THR A 59 ARG A 60 0 SHEET 2 B 5 LYS A 51 TYR A 55 -1 N TYR A 55 O THR A 59 SHEET 3 B 5 LEU A 39 GLN A 44 -1 N TRP A 41 O ILE A 54 SHEET 4 B 5 VAL A 91 ASN A 96 -1 O TYR A 93 N TYR A 42 SHEET 5 B 5 THR A 103 PHE A 104 -1 O THR A 103 N ASN A 96 SHEET 1 C 6 THR A 59 ARG A 60 0 SHEET 2 C 6 LYS A 51 TYR A 55 -1 N TYR A 55 O THR A 59 SHEET 3 C 6 LEU A 39 GLN A 44 -1 N TRP A 41 O ILE A 54 SHEET 4 C 6 VAL A 91 ASN A 96 -1 O TYR A 93 N TYR A 42 SHEET 5 C 6 THR A 108 GLU A 111 -1 O THR A 108 N TYR A 92 SHEET 6 C 6 SER A 10 THR A 12 1 N LEU A 11 O GLU A 111 SHEET 1 D 4 GLN B 3 GLN B 6 0 SHEET 2 D 4 VAL B 18 SER B 25 -1 O THR B 23 N GLN B 5 SHEET 3 D 4 THR B 78 LEU B 83 -1 O LEU B 81 N LEU B 20 SHEET 4 D 4 ALA B 68 ASP B 73 -1 N ILE B 71 O TYR B 80 SHEET 1 E 5 THR B 58 TYR B 60 0 SHEET 2 E 5 LEU B 45 ILE B 51 -1 N ARG B 50 O LYS B 59 SHEET 3 E 5 ASP B 32 GLN B 39 -1 N LYS B 38 O GLU B 46 SHEET 4 E 5 ALA B 92 GLU B 100 -1 O ALA B 97 N HIS B 35 SHEET 5 E 5 VAL B 110 TRP B 111 -1 O VAL B 110 N ARG B 98 SHEET 1 F 6 THR B 58 TYR B 60 0 SHEET 2 F 6 LEU B 45 ILE B 51 -1 N ARG B 50 O LYS B 59 SHEET 3 F 6 ASP B 32 GLN B 39 -1 N LYS B 38 O GLU B 46 SHEET 4 F 6 ALA B 92 GLU B 100 -1 O ALA B 97 N HIS B 35 SHEET 5 F 6 THR B 115 THR B 118 -1 O THR B 115 N TYR B 94 SHEET 6 F 6 GLU B 10 LEU B 11 1 N GLU B 10 O THR B 118 SSBOND 1 CYS A 23 CYS A 94 1555 1555 2.03 SSBOND 2 CYS B 22 CYS B 96 1555 1555 2.03 CISPEP 1 SER A 7 PRO A 8 0 -0.30 CISPEP 2 TYR A 100 PRO A 101 0 -0.32 SITE 1 AC1 7 LYS A 24 ASP A 76 GLN B 5 GLN B 6 SITE 2 AC1 7 ALA B 113 HOH B 158 HOH B 166 CRYST1 41.733 50.967 58.636 90.00 93.89 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023962 0.000000 0.001628 0.00000 SCALE2 0.000000 0.019621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017094 0.00000 MASTER 273 0 1 5 30 0 2 6 0 0 0 20 END